National Cade Prize for Innovation Names 21 Finalists
Judges for 2023’s National Cade Prize for Innovation named this year’s 21 Fibonacci Finalists. Finalists will compete to win $10,000 in their respective category group—Agriculture and Environmental, Healthcare/Biomedical, IT/Tech, Energy, and Wildcard. One of the five category winners will be selected as the Inventivity™ Grand Prize winner and take home an additional $50,000 prize. Two UF startups -- Lactovid and Analyz -- are listed among the Fibonacci Finalists.
Atsena Therapeutics Receives FDA Clearance of an Investigational Gene Therapy for X-Linked Retinoschisis
The U.S. Food and Drug Administration (FDA) has cleared Atsena Therapeutics' Investigational New Drug (IND) application for a Phase I/II clinical trial of ATSN-201 in patients with X-linked retinoschisis (XLRS). Atsena Therapeutics is a clinical-stage gene therapy company focused on bringing the life-changing power of genetic medicine to reverse or prevent blindness.
Oragenics, Inc. Announces Private Placement
Oragenics, a UF startup, is partnering with healthcare investors. They've privately placed 404,728 shares of common stock and 404,728 shares of Series E Mirroring Preferred Stock to fight infectious diseases, including coronaviruses.
UF Startup and Innovate Accelerate Resident, Micro Nano Technologies, Receives DOE Recognition in $135M Emission Reduction Campaign
DOE Awards $135M to 40 Projects Driving US Industrial Sector Decarbonization, Including UF Startup 'Micro Nano Technologies,' in Pursuit of Nationwide Net-Zero Emissions Economy by 2050.
Positive Results in Cancer Vaccine Trial for Merkel Cell Carcinoma and Cutaneous Squamous Cell Carcinoma
Morphogenesis, Inc., a biotechnology company focused on developing cancer vaccines, in partnership with CohBar, believes they have met their milestone with IFx-HU2.0, a cancer vaccine studied in advanced Merkel cell carcinoma and squamous cell carcinoma.
Finding Fires With Lightning Speed
To address this urgent problem, Fire Neural Network (FNN), a company based in Gainesville, Florida, is utilizing artificial intelligence (AI) to expedite the identification of devastating wildfires from 24 hours to just 40 seconds.
Baptist Health Study Suggests Plant-Based Amino Acid Drink Lessens Chemotherapy Side Effects
Baptist Health Louisville (Kentucky) is looking for ways to help cancer patients fight the side effects of chemotherapy.
Researchers are studying a new plant-based amino acid drink, Enterade, product of UF startup and UF Innovate | Accelerate alumnus company Entrinsic Bioscience, LLC.
Glint Pharmaceuticals Receives FDA IND Acceptance for Clinical Study for Phase 1/2 Clinical Trial of Antibiotic Drug-Releasing Contact Lens, ACL5
UF startup Glint Pharmaceuticals (Glint), a clinical-stage biotechnology company focused on developing a next-generation contact lens drug delivery technology, announced that the United States (U.S.) Food and Drug Administration (FDA) has accepted its Investigational New Drug (IND) application to evaluate its antibiotic drug delivery contact lens, ACL5. Glint anticipates beginning the investigation in Q2 2023.
Florida Tech Corridor Reaches for the Future
They’re among hundreds of innovations powered by the Florida High Tech Corridor, an initiative anchored by a trio of Florida research universities that rings Sumter County. Just marking its 27th anniversary, leaders of Florida’s tech triangle —UF in Gainesville, UCF in Orlando and USF in Tampa — say the future will bring even more revolution.
Startup Spotlight: Slice Engineering
Imagine 3D printing a body part for a major organ transplant surgery to save a person’s life. The backgrounds of both co-founders, Daniel Barousse and Chris Montgomery, have been influenced by this incredible technology. Their curiosity and insights into creating a better and more dynamic 3D printing experience for their clients were the geneses of UF Innovate | Accelerate client resident, Slice Engineering.
